Your browser doesn't support javascript.
loading
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky, Gennady; Mendhiratta, Neil; Daneshvar, Michael; Brugarolas, James; Ball, Mark W; Metwalli, Adam; Nathanson, Katherine L; Pierorazio, Phillip M; Boris, Ronald S; Singer, Eric A; Carlo, Maria I; Daly, Mary B; Henske, Elizabeth P; Hyatt, Colette; Middleton, Lindsay; Morris, Gloria; Jeong, Anhyo; Narayan, Vivek; Rathmell, W Kimryn; Vaishampayan, Ulka; Lee, Bruce H; Battle, Dena; Hall, Michael J; Hafez, Khaled; Jewett, Michael A S; Karamboulas, Christina; Pal, Sumanta K; Hakimi, A Ari; Kutikov, Alexander; Iliopoulos, Othon; Linehan, W Marston; Jonasch, Eric; Srinivasan, Ramaprasad; Shuch, Brian.
Afiliação
  • Bratslavsky G; Department of Urology, State University of New York (SUNY, Upstate Medical University, Syracuse, New York.
  • Mendhiratta N; Department of Urology, University of California Los Angeles, Los Angeles, California.
  • Daneshvar M; Department of Urology, State University of New York (SUNY, Upstate Medical University, Syracuse, New York.
  • Brugarolas J; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Ball MW; Department of Medicine, Division of Hematology-Oncology, University of Texas (UT) Southwestern Medical Center, Dallas, Texas.
  • Metwalli A; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Nathanson KL; Department of Surgery, Division of Urology, Howard University Hospital, Washington, District of Columbia.
  • Pierorazio PM; Division of Human Genetics and Translational Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Boris RS; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Singer EA; Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Carlo MI; Indiana University School of Medicine, Indianapolis, Indiana.
  • Daly MB; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Henske EP; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hyatt C; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Middleton L; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Morris G; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Jeong A; Department of Medicine, Division of Hematology-Oncology, University of Texas (UT) Southwestern Medical Center, Dallas, Texas.
  • Narayan V; Department of Urology, State University of New York (SUNY, Upstate Medical University, Syracuse, New York.
  • Rathmell WK; Department of Urology, University of California Los Angeles, Los Angeles, California.
  • Vaishampayan U; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lee BH; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Battle D; Department of Medicine, Vanderbilt University, Nashville, Tennessee.
  • Hall MJ; Department of Oncology, Karmanos Cancer Center/Wayne State University, Detroit, Michigan.
  • Hafez K; Driven To Cure, Silver Spring, Maryland.
  • Jewett MAS; The Kidney Cancer Research Alliance, Leesburg, Virginia.
  • Karamboulas C; Department of Surgery, Division of Urology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Pal SK; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Hakimi AA; Division of Urology, Department of Surgery, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Kutikov A; Division of Urology, Department of Surgery, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Iliopoulos O; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Linehan WM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jonasch E; Department of Surgery, Division of Urology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Srinivasan R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Shuch B; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Cancer ; 127(21): 3957-3966, 2021 Nov 01.
Article em En | MEDLINE | ID: mdl-34343338
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article